Screening for Endometrial Abnormalities in Overweight and Obese Women

St. Luke's-Roosevelt Hospital Center1 site in 1 country303 target enrollmentSeptember 2013

ConditionsEndometrial Cancer

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Endometrial Cancer
Sponsor: St. Luke's-Roosevelt Hospital Center
Enrollment: 303
Locations: 1
Primary Endpoint: A BMI cut-point will be identified at and above which an endometrial biopsy yields optimal sensitivity, specificity, positive predictive value, and negative predictive value to screen for endometrial cancer and abnormal pathologies
Status: Completed
Last Updated: 8 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to develop an endometrial biopsy screening program for endometrial cancer and its precursor lesions in overweight and obese women.

There is a BMI threshold at and above which optimal screening parameters exist for identifying endometrial cancer and its precursor lesions in overweight and/or obese women. Prevention, diagnosis and treatment of endometrial cancer and its precursor lesions in overweight and/or obese women offers substantial health benefits.

Registry

clinicaltrials.gov

Start Date

September 2013

End Date

March 31, 2016

Last Updated

8 years ago

Study Type

Interventional

Study Design

Single Group

Sex

Female

Investigators

Sponsor

St. Luke's-Roosevelt Hospital Center

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Outcomes

Primary Outcomes

A BMI cut-point will be identified at and above which an endometrial biopsy yields optimal sensitivity, specificity, positive predictive value, and negative predictive value to screen for endometrial cancer and abnormal pathologies

Time Frame: up to 1 year